<?xml version="1.0" encoding="UTF-8"?>
<p>Pharmaceutical interventions and medicines optimisation are essential components of the healthcare response to COVID-19. Medicines are a clinical priority and are required to support both patients and front-line clinical staff in their efforts to deal with the virus and to optimise patient care. As a result, there has been an unprecedented global demand on supportive medicines, particularly in critical care.</p>
